2Gratwohl A, Baldomero H, Schwendener A, et al. Predictability of hematopoietie stem cell transplantation rates. Haematologica, 2007 ; 92(12) : 1679 - 1686.
3Anderlini P. Donors, donors, and more donors. Blood, 2009; 114 (18) : 3721 -3722.
4Appelbaum FR. Choosing the source of stem cells for allogenic transplantation: no longer a peripheral issue. Blood, 1999; 94 (2) :381 -383.
5Champlin RE, Schmitz N, Horowitz MM ,et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT) . Blood, 2000; 95 (12) : 3702 - 3709.
6Tanimoto TE, Yamaguchi T, Tanaka Y, et al. Comparative analysis of clinieal outcomes after allogeneie bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients. BrJ Haematol, 2004; 125 (4) : 480- 493.
7Stem Cell Trialist s'Collaborative Group, Allogeneic peripheral blood stem cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta analysis of nine randomized trial. J Clin Oncol ,2005; 23 (22) : 5074 - 5087.
8Cavallaro AM, Lilleby K, Majolino I, et al. Three to six year followup of normal dlnors who received recombinant human granulocyte colonystimulating factor. Bone Marrow Transplant, 2000; 25( 1 ) : 85 -89.
9Mizuno S, Okamura T, lwasaki H, et al. Hypercoagulable state following transfusions of granulocyte obtained from granulocyte colonystimulating factor - stimulated donors. Int J Hematol, 2000 ; 72 (1)::115-117.
10Holig K, Kramer M, Kroschinsky F, et al. Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated donors: 12 years of single-center experience in 3928 donors. Blood, 2009;114(18) :3757 -3763.
